CCND2 and cholangiocarcinoma: Furthermore, miR-607 was found to be negatively regulated by TP73-AS1, while CCND2 was negatively regulated by miR-607, indicating that upregulation of TP73-AS1 promoted CCND2 by inhibiting miR-607 expression and thus promoted CC progression [15].